11th EFIM Day
Submitted by Catalina on 7 May 2026 - 15:16
Save the Date - 11th EFIM Day
Mark your calendars for the 11th EFIM Day, taking place in Brussels on Friday, October 16th, 2026.
Human medicines European public assessment report (EPAR): Atazanavir Viatris (previously Atazanavir Mylan), atazanavir, Date of authorisation: 22/08/2016, Revision: 21, Status: Authorised
Submitted by Anonymous (not verified) on 7 May 2026 - 15:02
Human medicines European public assessment report (EPAR): Atazanavir Viatris (previously Atazanavir Mylan), atazanavir, Date of authorisation: 22/08/2016, Revision: 21, Status: Authorised
Human medicines European public assessment report (EPAR): Ilumetri, tildrakizumab, Date of authorisation: 17/09/2018, Revision: 15, Status: Authorised
Submitted by Anonymous (not verified) on 7 May 2026 - 15:00
Human medicines European public assessment report (EPAR): Ilumetri, tildrakizumab, Date of authorisation: 17/09/2018, Revision: 15, Status: Authorised
Human medicines European public assessment report (EPAR): Comtan, entacapone, Date of authorisation: 22/09/1998, Revision: 28, Status: Authorised
Submitted by Anonymous (not verified) on 7 May 2026 - 14:54
Human medicines European public assessment report (EPAR): Comtan, entacapone, Date of authorisation: 22/09/1998, Revision: 28, Status: Authorised
Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 11, Status: Authorised
Submitted by Anonymous (not verified) on 7 May 2026 - 14:18
Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 11, Status: Authorised
EJCRIM is seeking an Assistant Editor
Submitted by Aneta on 7 May 2026 - 14:10
The European Journal of Case Reports in Internal Medicine (EJCRIM) - official journal of EFIM entirely dedicated to case reports - is seeking an Assistant Editor to join its editorial team and to be part of the Editorial Board of the journal.
This role is an opportunity for an experienced internal medicine physician to help to shape the dissemination of high-quality clinical case reports.
Please note that this is a voluntary position and does not include any financial compensation honorarium.
Key Responsibilities:
Human medicines European public assessment report (EPAR): Beovu, brolucizumab, Date of authorisation: 13/02/2020, Revision: 18, Status: Authorised
Submitted by Anonymous (not verified) on 7 May 2026 - 14:10
Human medicines European public assessment report (EPAR): Beovu, brolucizumab, Date of authorisation: 13/02/2020, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Truvelog Mix 30, insulin aspart, Date of authorisation: 25/04/2022, Revision: 3, Status: Withdrawn
Submitted by Anonymous (not verified) on 7 May 2026 - 14:00
Human medicines European public assessment report (EPAR): Truvelog Mix 30, insulin aspart, Date of authorisation: 25/04/2022, Revision: 3, Status: Withdrawn
EMEA-003192-PIP03-23
Submitted by Anonymous (not verified) on 7 May 2026 - 13:48
EMEA-003192-PIP03-23
EMA/PE/0000230710
Submitted by Anonymous (not verified) on 7 May 2026 - 13:45
EMA/PE/0000230710